Comments
Pharma major Dr Reddy's Laboratories on Thursday launched Pantoprazole sodium delayed-released tablets in the US market.
The tablets are bioequivalent generic version of Protonix in the US market, the Hyderabad-based company said in a release.
The drug had total US sales of approximately $1.8 billion for the 12 months ended September 30, 2010, according to IMS Health.
The US Food and Drug Administration (FDA) had approved Dr Reddy's Abbreviated New Drug Application for the tablets on Wednesday, the release added.
The tablets are generally indicated for relief from erosive esophagitis associated with gastroesophageal reflux disease.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.